Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$522.38 +6.04 (+1.17%)
At close: Sep 24, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) EV to EBIT (2009 - 2026)

Vertex Pharmaceuticals (VRTX) posted EV to EBIT of 94.63 for Q2 2026, up 1.36% on a QoQ basis from 93.36 in Q1 2026, and up 1.12% year-over-year from 93.58 in Q2 2025.

Analysis

Vertex Pharmaceuticals (VRTX) EV to EBIT (2009 - 2026) Analysis & Trends

Vertex Pharmaceuticals has reported EV to EBIT for 18 years, with the latest figure at 94.63 in Q2 2026.

  • On a quarterly basis, EV to EBIT rose 1.12% year-over-year to 94.63 in Q2 2026; TTM through Jun 2026 was 24.7, a 10.04% decrease from a year earlier, with the FY2025 full-year figure at 26.01, up 106.22% from the prior year.
  • EV to EBIT was 94.63 for Q2 2026 at Vertex Pharmaceuticals, up from 93.36 in the prior quarter.
  • The five-year high for EV to EBIT was 187.88 in Q1 2025, with the low at 32.76 in Q2 2024.
  • Average EV to EBIT over 5 years is 80.94, with a median of 87.92 recorded in 2024.
  • The sharpest annual moves came in 2024 and 2025: EV to EBIT tumbled 142.3% in 2024, then soared 385.65% in 2025.
  • Over 5 years, EV to EBIT stood at 61.38 in 2022, then jumped by 54.31% to 94.72 in 2023, then advanced by 0.17% to 94.89 in 2024, then slipped by 5.14% to 90.01 in 2025, then rose by 5.13% to 94.63 in 2026.
  • The last three EV to EBIT figures came in at 94.63 (Q2 2026), 93.36 (Q1 2026), and 90.01 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.63
Mar 31, 2026 93.36
Dec 31, 2025 90.01
Sep 30, 2025 78.55
Jun 30, 2025 93.58
Mar 31, 2025 187.88
Dec 31, 2024 94.89
Sep 30, 2024 101.54
Jun 30, 2024 -32.76
Mar 31, 2024 85.83
Dec 31, 2023 94.72
Sep 30, 2023 74.88
Jun 30, 2023 77.44
Mar 31, 2023 90.78
Dec 31, 2022 61.38
Sep 30, 2022 57.28
Jun 30, 2022 56.85
Mar 31, 2022 56.16
Dec 31, 2021 55.10
Sep 30, 2021 37.47
API Access

Vertex Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=VRTX&period=max&api_key=YOUR_API_KEY